$34.83
-0.42-1.19%
At Close: -
$34.83
00.00%
After Hours: Sep 20, 4:00 PM EDT
15 minutes delayed
Veracyte reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Veracyte using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $0.30 | $-0.03 | 1100.0 % |
Mar 2024 | 2024-05-07 | $-0.02 | $-0.17 | 88.2 % |
Dec 2023 | 2024-02-22 | $0.05 | $-0.09 | 155.6 % |
Sep 2023 | 2023-11-07 | $0.07 | $-0.15 | 146.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $114.43M | $99.99M | 14.4 % |
Mar 2024 | 2024-05-07 | $96.84M | $93.37M | 3.72 % |
Dec 2023 | 2024-02-22 | $98.20M | $91.96M | 6.78 % |
Sep 2023 | 2023-11-07 | $90.11M | $84.38M | 6.79 % |
Veracyte (VCYT) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $0.30, which beat the estimate of $-0.03.
The Actual Revenue was $114.4M, which beat the estimate of $100M.
Browse earnings estimates, EPS, and revenue on all stocks.